US Patent Issued to Pharmosa Biopharm on Feb. 17 for "Liposome compositions comprising weak acid drugs and uses thereof" (Taiwanese Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,437, issued on Feb. 17, was assigned to Pharmosa Biopharm Inc. (Taipei, Taiwan).

"Liposome compositions comprising weak acid drugs and uses thereof" was invented by Pei Kan (Taipei, Taiwan), Yi Fong Lin (New Taipei, Taiwan) and Ko Chieh Chen (Taipei, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical composition comprising a weak acid drug, with the use of a bicarbonate salt to achieve a high incorporation of the drug into the liposome and a better therapeutic efficacy. Also disclosed is a method for treating a respiratory disease using the pharmaceutical composition disclosed herein."

The patent...